0001396677-12-000049.txt : 20121217 0001396677-12-000049.hdr.sgml : 20121217 20121217171652 ACCESSION NUMBER: 0001396677-12-000049 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121213 FILED AS OF DATE: 20121217 DATE AS OF CHANGE: 20121217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HUME GARY M CENTRAL INDEX KEY: 0001265853 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23731 FILM NUMBER: 121269338 MAIL ADDRESS: STREET 1: C/O NUTRACEUTICAL INTERNATIONAL CORP STREET 2: 1400 KEARNS BLVD 2ND FL. CITY: PARK CITY STATE: UT ZIP: 84060 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NUTRACEUTICAL INTERNATIONAL CORP CENTRAL INDEX KEY: 0001050007 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870515089 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 BUSINESS PHONE: 4356556000 MAIL ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2012-12-13 0 0001050007 NUTRACEUTICAL INTERNATIONAL CORP NUTR 0001265853 HUME GARY M C/O NUTRACEUTICAL INTERNATIONAL CORP 1400 KEARNS BLVD 2ND FL. PARK CITY UT 84060 0 1 0 0 Executive Vice President Common Stock 2012-12-13 4 M 0 5000 12.32 A 8635.433 D Common Stock 2012-12-13 4 S 0 5000 16.6432 D 3635.433 D Common Stock 2012-12-14 4 M 0 3000 12.32 A 6635.433 D Common Stock 2012-12-14 4 S 0 3000 16.635 D 3635.433 D Employee Stock Option (right to buy) 12.32 2012-12-13 4 M 0 5000 0 D 2013-12-17 Common Stock 5000 5000 D Employee Stock Option (right to buy) 12.32 2012-12-14 4 M 0 3000 0 D 2013-12-17 Common Stock 3000 2000 D The price shown in Column 4 is a weighted average sale price. The price range for the sales is $16.52 to $16.75. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The price shown in Column 4 is a weighted average sale price. The price range for the sales is $16.60 to $16.73. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The option vested in six equal installments every six months beginning on June 17, 2004. /s/ Alison Pitt, attorney in fact 2012-12-17